EUVIMEDEUVIMED entdecken
Crossref

Evaluation of MMP-13 and Micro RNA-138 as prognostic biomarkers for breast cancer in Egyptian women patients

Hossam Elmasry, Sally M Khadrawy, Mahmoud M Kamel, Mona H Ibrahim, Abdelaziz S A Abuelsaad, Mohamed I Zanaty

Pathology - Research and Practice · 2024-01 · 253 · 155045

DOI: 10.1016/j.prp.2023.155045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024-01. Verfasst von Hossam Elmasry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, Egypt; Bah…. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Elevated serum levels of MMP-13 are linked to tumor growth and metastasis, while miR-138 dysregulation is observed in breast cancer cases. The aim of this study is to investigate the expression of miR-138 and MMP-13 levels as potential biomarkers for the prognosis of breast cancer. PATIENTS AND METHOD: In this retrospective case-control study, 119 female subjects were recruited and divided into three groups. MMP-13 level was measured using Enzyme Linked Immunosorbent Assay (ELISA), while real-time PCR technique was employed to quantify miR-138 expression. RESULTS: Both non-metastatic and metastatic groups showed significantly higher levels of serum MMP-13 compared to other groups. MMP-13 levels are significantly increased among patients with advanced tumor size, lymph node metastasis, and triple-negative breast cancer cases. An inverse significant association between MMP-13 levels and response to treatment was observed. Expression of miR-138 underwent a significant down-regulation in breast cancer patients, and a statistically significant association was established between miR-138 expression and triple-negative breast cancer cases. A positive association was detected between the increase in miR-138 expression and the good response to treatment. The expression of miR-138 was inversely correlated with the MMP-13 levels. CONCLUSION: MMP-13 levels were significantly higher in breast cancer, especially in advanced cases, suggesting its role in promoting tumor invasion and metastasis. MiR-138 was down-regulated in breast cancer, especially in triple-negative breast cancer patients, rendering it a promising biomarker for triple-negative breast cancer. Modulation of miR-138 expression and MMP-13 levels may represent therapeutic targets for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsTriple Negative Breast NeoplasmsHumansFemalePrognosisCase-Control StudiesRetrospective StudiesEgyptMatrix Metalloproteinase 13Biomarkers, TumorGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

Breast CancerMMP-13MetastasisMiR-138

Substanzen

MicroRNAsMatrix Metalloproteinase 13Biomarkers, TumorMIRN138 microRNA, human

Autor:innen und Institutionen

  • Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, Egypt; Baheya Centre of Early Detection and Treatment of Breast Cancer, Giza, Eg…
  • Genetics and Molecular Biology, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef 62521, Egypt.
  • Clinical and Chemical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt. Electronic address: mahmoud.kamel@nci.cu.edu.eg.
  • Clinical and Chemical Pathology Department, Medical Division, National Research Centre, Cairo, Egypt.
  • Immunology Division, Zoology Department, Faculty of Science, Beni-Suef University, Beni-Suef 62521, Egypt.
  • Biotechnology and Life Sciences Department, Faculty of Postgraduate Studies for Advanced Sciences (PSAS), Beni-Suef University, Beni-Suef, Egypt.

Zitieren

APA

Elmasry, H., Khadrawy, S. M., Kamel, M. M., Ibrahim, M. H., Abuelsaad, A. S. A., & Zanaty, M. I. (2024). Evaluation of MMP-13 and Micro RNA-138 as prognostic biomarkers for breast cancer in Egyptian women patients. Pathology - Research and Practice, 253, 155045. https://doi.org/10.1016/j.prp.2023.155045

Vancouver

Elmasry H, Khadrawy SM, Kamel MM, Ibrahim MH, Abuelsaad ASA, Zanaty MI. Evaluation of MMP-13 and Micro RNA-138 as prognostic biomarkers for breast cancer in Egyptian women patients. Pathology - Research and Practice. 2024;253:155045. doi:10.1016/j.prp.2023.155045

BibTeX
@article{Elmasry2024,
  author = {Elmasry, Hossam and Khadrawy, Sally M and Kamel, Mahmoud M and Ibrahim, Mona H and Abuelsaad, Abdelaziz S A and Zanaty, Mohamed I},
  title = {Evaluation of MMP-13 and Micro RNA-138 as prognostic biomarkers for breast cancer in Egyptian women patients},
  journal = {Pathology - Research and Practice},
  year = {2024},
  volume = {253},
  pages = {155045},
  doi = {10.1016/j.prp.2023.155045}
}
Kostenlos starten →